APA (7th ed.) Citation

Müller, O., Mockenhaupt, F. P., Marks, B., Meissner, P., Coulibaly, B., Kuhnert, R., . . . Mansmann, U. (2013). Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: A synopsis of four RCTs. Pharmacoepidemiology and drug safety, 22(4), . https://doi.org/10.1002/pds.3370

Chicago Style (17th ed.) Citation

Müller, Olaf, et al. "Haemolysis Risk in Methylene Blue Treatment of G6PD-sufficient and G6PD-deficient West-African Children with Uncomplicated Falciparum Malaria: A Synopsis of Four RCTs." Pharmacoepidemiology and Drug Safety 22, no. 4 (2013). https://doi.org/10.1002/pds.3370.

MLA (9th ed.) Citation

Müller, Olaf, et al. "Haemolysis Risk in Methylene Blue Treatment of G6PD-sufficient and G6PD-deficient West-African Children with Uncomplicated Falciparum Malaria: A Synopsis of Four RCTs." Pharmacoepidemiology and Drug Safety, vol. 22, no. 4, 2013, https://doi.org/10.1002/pds.3370.